Singapore's regulatory agency Health Sciences Authority (HSA), since its establishment in 2001, has built a smart regulatory environment to support the development... Read more
Contrast induced nephropathy (CIN) is a form of kidney damage caused by the toxic effects of dyes (contrast) used by cardiologists during X-ray of heart and blood... Read more
Are public-private partnerships the way forward for emerging countries of Asia? The trend says so. Global analyst company, PricewaterhouseCoopers, suggests that... Read more
Countries in Asia are pushing policies to attract investments. India has taken many steps to encourage investments and tweaked regulations to meet international... Read more
Elastatherapy is a technology that has the potential to reverse ageing process and enable skin regeneration. The technology uses human protein Elastin to naturally... Read more
Asia's two leading economies, India and China are actively working on new strategies to attract money into the bioscience sector, seeking significant foreign investment... Read more
Can DNA vaccines be the answer to diseases such as malaria and influenza? Though DNA-based vaccines have emerged as appealing alternatives to conventional ones,... Read more
TriReme Medical, a US-based start-up medical devices company dedicated to the development and manufacturing of innovative devices for the treatment of complex vascular... Read more
A team of researchers at the Institute of Bioengineering and Nanotechnology (IBN), A*STAR in Singapore, developed a micro-fabricated silicon microsieve device that... Read more
Recently, Health Sciences Authority (HSA) of Singapore enhanced its regulatory framework for low-risk Class A and B medical devices to ensure lower regulatory fees... Read more
Reforms in government policies and initiatives have helped in setting focus for bioscience companies, which has resulted in an enhanced manpower pool in Asia. ... Read more
While many multinational companies have reduced their manpower to cut costs in 2011, regional companies in Asia have gone for the opposite. The primary reason for... Read more
At a time when multinational companies in bioscience industry are opting for job cuts, the lure of international markets is making companies in India and China strengthen... Read more
The challenges of providing quality healthcare to people are many for emerging nations in the Asia Pacific region. From getting qualified doctors and specialists... Read more
AB SCIEX, a global leader in life science analytical technologies, recently opened its new Asia Pacific Application and Training Centre. Located in Singapore's biomedical... Read more
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
